| scholarly article | Q13442814 |
| P50 | author | Nazareno Suardi | Q102072899 |
| Alexandre de la Taille | Q114316432 | ||
| Charles Karim Bensalah | Q114316494 | ||
| Roberto Bertini | Q114316544 | ||
| Richard Zigeuner | Q114316661 | ||
| Jacques Tostain | Q114316670 | ||
| Jean-Luc Descotes | Q114404119 | ||
| Jean-Jacques Rambeaud | Q114404140 | ||
| Claudio Jeldres | Q37831565 | ||
| Arnaud Méjean | Q42295427 | ||
| Umberto Capitanio | Q57565904 | ||
| Jean-Jacques Patard | Q63133652 | ||
| Francesco Montorsi | Q67191520 | ||
| Vincenzo Ficarra | Q87901390 | ||
| Walter Artibani | Q89781353 | ||
| Laurent J Salomon | Q90056553 | ||
| Luca Cindolo | Q90664564 | ||
| Peter Mulder | Q92549745 | ||
| Pierre I Karakiewicz | Q97332033 | ||
| P2093 | author name string | Antoine Valéri | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 287-295 | |
| P577 | publication date | 2008-07-25 | |
| P1433 | published in | European Urology | Q15763991 |
| P1476 | title | A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. | |
| P478 | volume | 55 |
| Q50913242 | A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies. |
| Q57063318 | A novel preoperative model to predict 90-day surgical mortality in patients considered for renal cell carcinoma surgery |
| Q44666830 | A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma |
| Q38557322 | Accuracy capabilities comparisons between Karakiewicz, Kattan and Cindolo nomograms in predicting outcomes for renal cancer carcinoma: A systematic review and meta-analysis |
| Q38057793 | Active surveillance for small renal tumors: have clinical concerns been addressed so far? |
| Q86425425 | Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decades |
| Q38001225 | Approach to the small renal mass: to treat or not to treat |
| Q44187935 | Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study. |
| Q33597715 | Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer |
| Q38913181 | Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study |
| Q37765583 | Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma? |
| Q37172780 | Clear Cell Renal Cell Carcinoma: Associations Between CT Features and Patient Survival |
| Q37054062 | Clinical Outcome of Small Renal Cell Carcinoma after Delayed Surgery versus Immediate Surgery |
| Q36891803 | Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery |
| Q41055563 | Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma |
| Q44087258 | Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities |
| Q44255441 | Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? |
| Q64075550 | Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma |
| Q44216237 | Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series |
| Q44323809 | External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma |
| Q51687823 | Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. |
| Q61448050 | Impact of diabetes mellitus on the prognostic value of the neutrophil-lymphocyte ratio in renal cell carcinoma |
| Q34363552 | Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein |
| Q87401441 | Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics |
| Q47158686 | Inherent characteristics of metachronous metastatic renal cell carcinoma in the era of targeted agents |
| Q46125956 | Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma |
| Q45944510 | Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus. |
| Q37400502 | Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma |
| Q37974504 | Predictive models for the practical management of renal cell carcinoma |
| Q93185517 | Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery |
| Q99233212 | Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort |
| Q34899343 | Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. |
| Q35236283 | Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis |
| Q41089343 | Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma |
| Q36287965 | Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma. |
| Q30234787 | Risk Assessment in Small Renal Masses: A Review Article. |
| Q41144832 | Role of Contrast Enhancement and Corrected Attenuation Values of Renal Tumors in Predicting Renal Cell Carcinoma (RCC) Subtypes: Protocol for a Triphasic Multi-Slice Computed Tomography (CT) Procedure |
| Q28084949 | Serum and urine biomarkers for human renal cell carcinoma |
| Q34757109 | Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma |
| Q38013775 | Surgical treatment of atypical metastasis from renal cell carcinoma (RCC). |
| Q37579220 | There is no place for targeted therapy neoadjuvant treatment in Polish Health System - An analysis of radical nephrectomies in patients with large kidney tumors |
| Q54318661 | [CCAFU Recommendations 2013: Renal cancer]. |
| Q89669123 | [Follow-up of renal cell carcinoma based on stage and initial treatment] |
| Q82728667 | [Recommendations Onco-Urology 2010: Kidney cancer] |
Search more.